Former NFL Player Is First Diagnosis of CTE in Living Patient
Researchers may be close to IDing the brain disease while a patient is still alive.
Reuters
Scientists say they have finally been able to detect evidence of chronic traumatic encephalopathy—or CTE—in a living patient. A new study, undertaken by lead author and pathologist Bennet Omalu, suggests that experts can diagnose the disease while a patient is still alive by detecting the presence and deposits of tau proteins—instead of requiring an autopsy for formal diagnosis. Omalu told CNN that the unnamed player in the study is actually Fred McNeill, who played for the NFL’s Minnesota Vikings and died in 2015. Omalu—whose work the 2015 film Concussion was based on—said he initially diagnosed McNeill in 2012 using a brain scan that traced tau, a signature protein of CTE. They later confirmed that diagnosis with an autopsy, after McNeill passed away. Omalu’s case study was published in Neurosurgery this week.
Unlock a year of full access to The Daily Beast for $35.
Monthly
$1
First monththen $5.99/month
Unlimited access (web + app)
Exclusive ad-free newsletters
Commenting access
Daily crossword
Sneak peek of launches & events
Auto-renews at $5.99 monthly. Cancel anytime
Annual
$35
First yearthen $59.99/year
Discounted annual rate - Save 47%
Unlimited access (web + app)
Exclusive ad-free newsletters
Commenting access
Daily crossword
Sneak peek of launches & events
Auto-renews at $59.99 yearly. Cancel anytime
Best Value
Premium
$79
First yearthen $119.99/year
Discounted annual rate
Full access to the Daily Beast Substack ($60 value)*
Premium ad-free reading
Unlimited access (web + app)
Exclusive ad-free newsletters
Commenting access
Daily crossword
Sneak peek of launches & events
Auto-renews at $119.99 yearly. Cancel anytime
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Looks like you already have a subscription!
Account (completed)
Payment (completed)
Confirmation (completed)
You're all set!
Thanks for subscribing.
1Account
2Payment
3Confirmation
Sign in or create an account
OR
Loading subscription options
Register below to read this article for free or subscribe to unlock unlimited access to The Daily Beast.
Monthly
$1
First monththen $5.99/month
Unlimited access (web + app)
Exclusive ad-free newsletters
Commenting access
Daily crossword
Sneak peek of launches & events
Auto-renews at $5.99 monthly. Cancel anytime
Annual
$35
First yearthen $59.99/year
Discounted annual rate - Save 47%
Unlimited access (web + app)
Exclusive ad-free newsletters
Commenting access
Daily crossword
Sneak peek of launches & events
Auto-renews at $59.99 yearly. Cancel anytime
Best Value
Premium
$79
First yearthen $119.99/year
Discounted annual rate
Full access to the Daily Beast Substack ($60 value)*
Premium ad-free reading
Unlimited access (web + app)
Exclusive ad-free newsletters
Commenting access
Daily crossword
Sneak peek of launches & events
Auto-renews at $119.99 yearly. Cancel anytime
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.